Louisiana State Employees Retirement System Purchases Shares of 29,200 Encompass Health Corporation $EHC

Posted by George Bondi on Jun 29th, 2026

Louisiana State Employees Retirement System bought a new stake in shares of Encompass Health Corporation (NYSE:EHC – Free Report) during the 1st quarter, HoldingsChannel.com reports. The fund bought 29,200 shares of the company’s stock, valued at approximately $2,825,000.

A number of other institutional investors and hedge funds have also bought and sold shares of EHC. WPG Advisers LLC increased its position in shares of Encompass Health by 73.3% during the 4th quarter. WPG Advisers LLC now owns 324 shares of the company’s stock valued at $34,000 after purchasing an additional 137 shares during the last quarter. Flagship Harbor Advisors LLC purchased a new position in shares of Encompass Health in the 4th quarter worth about $37,000. Caitong International Asset Management Co. Ltd grew its position in Encompass Health by 36,200.0% during the third quarter. Caitong International Asset Management Co. Ltd now owns 363 shares of the company’s stock valued at $46,000 after buying an additional 362 shares during the period. Aster Capital Management DIFC Ltd bought a new position in Encompass Health during the fourth quarter valued at about $55,000. Finally, Covestor Ltd increased its holdings in Encompass Health by 24.4% during the fourth quarter. Covestor Ltd now owns 540 shares of the company’s stock worth $57,000 after buying an additional 106 shares during the last quarter. 97.25% of the stock is owned by hedge funds and other institutional investors.

Encompass Health Price Performance

Encompass Health stock opened at $101.33 on Monday. The firm has a market capitalization of $10.05 billion, a P/E ratio of 16.92, a PEG ratio of 2.21 and a beta of 0.72. Encompass Health Corporation has a one year low of $92.77 and a one year high of $127.99. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.17 and a quick ratio of 1.17. The business has a fifty day moving average price of $103.25 and a 200-day moving average price of $103.54.

Encompass Health (NYSE:EHC – Get Free Report) last issued its earnings results on Thursday, April 30th. The company reported $1.60 EPS for the quarter, topping the consensus estimate of $1.51 by $0.09. Encompass Health had a return on equity of 18.28% and a net margin of 10.04%.The business had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.57 billion. During the same quarter last year, the company earned $1.37 EPS. The firm’s revenue was up 9.0% compared to the same quarter last year. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. As a group, equities research analysts forecast that Encompass Health Corporation will post 5.97 EPS for the current year.

Encompass Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be paid a dividend of $0.19 per share. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $0.76 annualized dividend and a yield of 0.8%. Encompass Health’s dividend payout ratio (DPR) is currently 12.69%.

Insider Buying and Selling

In other Encompass Health news, EVP Patrick William Tuer sold 682 shares of the business’s stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $104.56, for a total value of $71,309.92. Following the completion of the transaction, the executive vice president owned 24,755 shares of the company’s stock, valued at $2,588,382.80. The trade was a 2.68% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.80% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the stock. Weiss Ratings lowered shares of Encompass Health from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday. Wall Street Zen raised Encompass Health from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Barclays decreased their target price on Encompass Health from $153.00 to $140.00 and set an “overweight” rating for the company in a research report on Tuesday, May 5th. TD Cowen initiated coverage on Encompass Health in a research note on Thursday, May 28th. They issued a “buy” rating and a $125.00 target price on the stock. Finally, Leerink Partners set a $152.00 price target on Encompass Health in a research note on Friday, May 22nd. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $143.86.

Check Out Our Latest Analysis on EHC

Encompass Health Profile

(Free Report)

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.